{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:13:33Z","timestamp":1787163213724,"version":"build-2736575974"},"reference-count":60,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17ek0109167h0002"],"award-info":[{"award-number":["17ek0109167h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007786","name":"National Center for Child Health and Development","doi-asserted-by":"publisher","award":["2020B-2"],"award-info":[{"award-number":["2020B-2"]}],"id":[{"id":"10.13039\/100007786","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007786","name":"National Center for Child Health and Development","doi-asserted-by":"publisher","award":["2023B-17"],"award-info":[{"award-number":["2023B-17"]}],"id":[{"id":"10.13039\/100007786","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ymthe.2023.09.004","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T21:22:35Z","timestamp":1694553755000},"page":"3424-3440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Myelodysplasia after clonal hematopoiesis with APOBEC3-mediated CYBB inactivation in retroviral gene therapy for X-CGD"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9610-0900","authenticated-orcid":false,"given":"Toru","family":"Uchiyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinao","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Nakabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiro","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohji","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyoki","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akane","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Minegishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Edasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Shimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Akiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiko","family":"Sato-Otsubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Mizukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Akashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Nunoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Onodera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2023.09.004_bib1","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.gene.2013.03.098","article-title":"Gene therapy for PIDs: progress, pitfalls and prospects","volume":"525","author":"Mukherjee","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.ymthe.2023.09.004_bib2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1517\/14712598.2014.895811","article-title":"Gene therapy for inherited immunodeficiency","volume":"14","author":"Touzot","year":"2014","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.ymthe.2023.09.004_bib3","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1126\/science.288.5466.669","article-title":"Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease","volume":"288","author":"Cavazzana-Calvo","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2023.09.004_bib4","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJMoa012616","article-title":"Sustained correction of X-linked severe combined immunodeficiency by ex\u00a0vivo gene therapy","volume":"346","author":"Hacein-Bey-Abina","year":"2002","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2023.09.004_bib5","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1056\/NEJMoa1000164","article-title":"Efficacy of gene therapy for X-linked severe combined immunodeficiency","volume":"363","author":"Hacein-Bey-Abina","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2023.09.004_bib6","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1126\/science.1070104","article-title":"Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning","volume":"296","author":"Aiuti","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2023.09.004_bib7","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa0805817","article-title":"Gene therapy for immunodeficiency due to adenosine deaminase deficiency","volume":"360","author":"Aiuti","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2023.09.004_bib8","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1056\/NEJMoa1003548","article-title":"Stem-cell gene therapy for the Wiskott-Aldrich syndrome","volume":"363","author":"Boztug","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2023.09.004_bib9","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2023.09.004_bib10","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1172\/JCI35798","article-title":"Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients","volume":"118","author":"Howe","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2023.09.004_bib11","doi-asserted-by":"crossref","first-page":"227ra33","DOI":"10.1126\/scitranslmed.3007280","article-title":"Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity","volume":"6","author":"Braun","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2023.09.004_bib12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1126\/science.1091667","article-title":"Gene therapy insertional mutagenesis insights","volume":"303","author":"Dav\u00e9","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2023.09.004_bib13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJM200301163480314","article-title":"A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency","volume":"348","author":"Hacein-Bey-Abina","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2023.09.004_bib14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal T\u00a0cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2023.09.004_bib15","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nm1393","article-title":"Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1","volume":"12","author":"Ott","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2023.09.004_bib16","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nm.2088","article-title":"Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease","volume":"16","author":"Stein","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2023.09.004_bib17","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1182\/blood-2009-05-222760","article-title":"Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils","volume":"115","author":"Kang","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2023.09.004_bib18","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1038\/mt.2011.166","article-title":"Retroviral gene therapy for X-linked chronic granulomatous disease: results from phase I\/II trial","volume":"19","author":"Kang","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2023.09.004_bib19","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1093\/nar\/gki343","article-title":"Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F\/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities","volume":"33","author":"Langlois","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2023.09.004_bib20","doi-asserted-by":"crossref","first-page":"8201","DOI":"10.1128\/JVI.79.13.8201-8207.2005","article-title":"Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion","volume":"79","author":"Doehle","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2023.09.004_bib21","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/gt.2010.177","article-title":"APOBEC3-mediated hypermutation of retroviral vectors produced from some retrovirus packaging cell lines","volume":"18","author":"Miller","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2023.09.004_bib22","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1128\/JVI.01371-07","article-title":"Species-specific restriction of apobec3-mediated hypermutation","volume":"82","author":"Browne","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2023.09.004_bib23","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nature11881","article-title":"APOBEC3B is an enzymatic source of mutation in breast cancer","volume":"494","author":"Burns","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2023.09.004_bib24","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/ng.3378","article-title":"An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers","volume":"47","author":"Chan","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2023.09.004_bib25","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41586-022-04972-y","article-title":"Mechanisms of APOBEC3 mutagenesis in human cancer cells","volume":"607","author":"Petljak","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2023.09.004_bib26","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nri1489","article-title":"Retroviral restriction by APOBEC proteins","volume":"4","author":"Harris","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2023.09.004_bib27","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tibs.2007.01.004","article-title":"APOBEC-mediated viral restriction: not simply editing?","volume":"32","author":"Holmes","year":"2007","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ymthe.2023.09.004_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008173","article-title":"Mouse APOBEC3 interferes with autocatalytic cleavage of murine leukemia virus Pr180gag-pol precursor and inhibits Pr65gag processing","volume":"15","author":"Hakata","year":"2019","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2023.09.004_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004145","article-title":"Different modes of retrovirus restriction by human APOBEC3A and APOBEC3G in\u00a0vivo","volume":"10","author":"Stavrou","year":"2014","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2023.09.004_bib30","doi-asserted-by":"crossref","first-page":"7659","DOI":"10.1128\/JVI.00967-14","article-title":"Incorporation of mouse APOBEC3 into murine leukemia virus virions decreases the activity and fidelity of reverse transcriptase","volume":"88","author":"Boi","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2023.09.004_bib31","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ymthe.2016.11.012","article-title":"Targeted repair of CYBB in X-CGD iPSCs requires retention of intronic sequences for expression and functional correction","volume":"25","author":"Sweeney","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2023.09.004_bib32","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1182\/blood-2011-01-330050","article-title":"Accumulation of oxidative DNA damage restricts the self-renewal capacity of human hematopoietic stem cells","volume":"118","author":"Yahata","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2023.09.004_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2015.46","article-title":"An assessment of the effects of ectopic gp91phox expression in XCGD iPSC-derived neutrophils","volume":"2","author":"Lin","year":"2015","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2023.09.004_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116410","article-title":"NADPH oxidase-dependent production of reactive oxygen species induces endoplasmatic reticulum stress in neutrophil-like HL60 cells","volume":"10","author":"Kuwabara","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ymthe.2023.09.004_bib35","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/nature02989","article-title":"Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells","volume":"431","author":"Ito","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2023.09.004_bib36","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nm1388","article-title":"Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells","volume":"12","author":"Ito","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2023.09.004_bib37","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/mt.2010.226","article-title":"Biochemical correction of X-CGD by a novel chimeric promoter regulating high levels of transgene expression in myeloid cells","volume":"19","author":"Santilli","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2023.09.004_bib38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/humc.2017.245","article-title":"Non-clinical efficacy and safety studies on G1XCGD, a lentiviral vector for ex\u00a0vivo gene therapy of X-linked chronic granulomatous disease","volume":"29","author":"Brendel","year":"2018","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.ymthe.2023.09.004_bib39","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41591-019-0735-5","article-title":"Lentiviral gene therapy for X-linked chronic granulomatous disease","volume":"26","author":"Kohn","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2023.09.004_bib41","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1182\/blood-2009-06-229757","article-title":"Cellular barcoding tool for clonal analysis in the hematopoietic system","volume":"115","author":"Gerrits","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2023.09.004_bib42","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nature12013","article-title":"Diverse and heritable lineage imprinting of early haematopoietic progenitors","volume":"496","author":"Naik","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2023.09.004_bib43","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.stem.2014.01.020","article-title":"Clonal tracking of rhesus macaque hematopoiesis highlights a distinct lineage origin for natural killer cells","volume":"14","author":"Wu","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2023.09.004_bib44","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.celrep.2014.01.016","article-title":"Determining lineage pathways from cellular barcoding experiments","volume":"6","author":"Peri\u00e9","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2023.09.004_bib45","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.stem.2016.04.016","article-title":"In\u00a0vivo tracking of human hematopoiesis reveals patterns of clonal dynamics during early and steady-state reconstitution phases","volume":"19","author":"Biasco","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2023.09.004_bib46","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.4049\/jimmunol.1501504","article-title":"APOBEC3 proteins in viral immunity","volume":"195","author":"Stavrou","year":"2015","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2023.09.004_bib47","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1056\/NEJMoa1007097","article-title":"Residual NADPH oxidase and survival in chronic granulomatous disease","volume":"363","author":"Kuhns","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2023.09.004_bib48","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1182\/blood-2002-05-1459","article-title":"High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients","volume":"101","author":"Barjesteh van Waalwijk van Doorn-Khosrovani","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2023.09.004_bib49","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1200\/JCO.2010.29.2771","article-title":"Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)\/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia","volume":"28","author":"Lugthart","year":"2010","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ymthe.2023.09.004_bib50","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/bjh.13898","article-title":"Review: aberrant EVI1 expression in acute myeloid leukaemia","volume":"172","author":"Hinai","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymthe.2023.09.004_bib51","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000040830","article-title":"cis-Active elements of Friend spleen focus-forming virus: from disease induction to disease prevention","volume":"99","author":"Baum","year":"1998","journal-title":"Acta Haematol."},{"key":"10.1016\/j.ymthe.2023.09.004_bib52","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/mt.2008.5","article-title":"Physiological promoters reduce the genotoxic risk of integrating gene vectors","volume":"16","author":"Zychlinski","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2023.09.004_bib53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/sj.thj.6200143","article-title":"Structural rearrangements of chromosome 3 in 57 patients with acute myeloid leukemia: clinical, hematological and cytogenetic features","volume":"3","author":"Charrin","year":"2002","journal-title":"Hematol. J."},{"key":"10.1016\/j.ymthe.2023.09.004_bib54","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cancergencyto.2005.10.007","article-title":"Translocation (3;8)(q26;q24): a recurrent chromosomal abnormality in myelodysplastic syndrome and acute myeloid leukemia","volume":"166","author":"Lin","year":"2006","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.ymthe.2023.09.004_bib55","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/sj.leu.2403346","article-title":"Translocation t(2;3)(p15-23;q26-27) in myeloid malignancies: report of 21 new cases, clinical, cytogenetic and molecular genetic features","volume":"18","author":"Stevens-Kroef","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.ymthe.2023.09.004_bib56","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/sj.leu.2404020","article-title":"Characterization of a recurrent translocation t(2;3)(p15-22;q26) occurring in acute myeloid leukaemia","volume":"20","author":"Trubia","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.ymthe.2023.09.004_bib57","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1182\/blood-2009-12-259390","article-title":"WT1 mutation in 470 adult patients with acute myeloid leukemia: stability during disease evolution and implication of its incorporation into a survival scoring system","volume":"115","author":"Hou","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2023.09.004_bib58","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.celrep.2014.11.004","article-title":"DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia","volume":"9","author":"Rampal","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2023.09.004_bib59","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.molcel.2014.12.023","article-title":"WT1 recruits TET2 to regulate its target gene expression and suppress leukemia cell proliferation","volume":"57","author":"Wang","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymthe.2023.09.004_bib60","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ymthe.2020.09.030","article-title":"Hematopoietic tumors in a mouse model of X-linked chronic granulomatous disease after lentiviral vector-mediated gene therapy","volume":"29","author":"Jofra Hern\u00e1ndez","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2023.09.004_bib61","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.omtm.2021.10.003","article-title":"Nonconditioned ADA-SCID gene therapy reveals ADA requirement in the hematopoietic system and clonal dominance of vector-marked clones","volume":"23","author":"Uchiyama","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001623004914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001623004914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:47:08Z","timestamp":1778816828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001623004914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":60,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1525001623004914"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2023.09.004","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myelodysplasia after clonal hematopoiesis with APOBEC3-mediated CYBB inactivation in retroviral gene therapy for X-CGD","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2023.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}